| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-743921 | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-08 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | GSK461364 | CTRPv2 | pan-cancer | AAC | -0.18 | 4e-08 |
| mRNA | KX2-391 | CTRPv2 | pan-cancer | AAC | -0.18 | 6e-08 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | -0.16 | 6e-08 |
| mRNA | BI-2536 | CTRPv2 | pan-cancer | AAC | -0.18 | 1e-07 |
| mRNA | Doxorubicin | CTRPv2 | pan-cancer | AAC | -0.17 | 1e-07 |
| mRNA | dabrafenib | GDSC1000 | pan-cancer | AAC | 0.17 | 2e-07 |
| mRNA | serdemetan:SCH-529074 (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.19 | 2e-07 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | -0.18 | 3e-07 |